Intrinsiqq
Diebold Nixdorf Inc. logo

Diebold Nixdorf Inc. Insider Trading

DBD

⊜ Compare
Last 12 months

Insiders bought 300K on the open market and sold nothing.

Net open-market
+300K
4 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
3 / 0
executives and directors
Last open-market buy
Jul 2026
Jul 31, 2026

Get an email when DBD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jul 31
    Thomas S Timko
    EVP, CFO · bought 700 at $72.29
    51K
    0.9% of stake
  • Jun 26No plan
    Brian D Connolly
    Large holder · sold 100,000 at $84.80
    $8.48M
    2.4% of stake
  • Jun 24 – 25No plan
    Brian D Connolly
    Large holder · sold 231,464 at avg $83.96
    $19.4M
    5.2% of stake
  • Jun 12 – 15No plan
    Brian D Connolly
    Large holder · sold 161,440 at avg $82.14
    $13.3M
    3.5% of stake
  • Jun 10 – 11No plan
    Millstreet Capital Management LLC
    Large holder · sold 18,768 at avg $82.08
    $1.54M
    0.4% of stake
  • Jun 8No plan
    Brian D Connolly
    Large holder · sold 88,334 at $82.99
    $7.33M
    1.9% of stake
  • May 26 – 27
    Octavio Marquez
    President and CEO · bought 1,250 at avg $79.46
    99K
    0.6% of stake
  • May 22
    Jonathan Myers
    EVP, Chief Revenue Officer · bought 1,360 at $73.41
    100K
    3.1% of stake
  • May 22
    Thomas S Timko
    EVP, CFO · bought 672 at $74.36
    50K
    0.9% of stake
  • Apr 15 – 16No plan
    Craig Kelleher
    Large holder · sold 112,305 at avg $85.07
    $9.55M
    2.3% of stake
  • Apr 8No plan
    Millstreet Capital Management LLC
    Large holder · sold 399,929 at $82.42
    $33M
    7.7% of stake
  • Jan 15No plan
    Craig Kelleher
    Large holder · sold 500,000 at $68.00
    $34M
    8.7% of stake
  • Nov 5, 2025 – Nov 6, 2025No plan
    Craig Kelleher
    Large holder · sold 251,726 at avg $63.19
    $15.9M
    4.2% of stake
  • Sep 18, 2025No plan
    Millstreet Capital Management LLC
    Large holder · sold 38,963 at $60.08
    $2.34M
    0.6% of stake
  • Sep 16, 2025No plan
    Millstreet Capital Management LLC
    Large holder · sold 20,000 at $60.11
    $1.2M
    0.3% of stake
  • May 9, 2025
    Frank Tobias Baur
    EVP of Operational Excellence · bought 700 at $46.12
    32K
    1.8% of stake
  • Feb 28, 2025No plan
    Emanuel R Pearlman
    Director · sold 2,000 at avg $43.68
    87K
    4.8% of stake
  • Feb 27, 2025No plan
    Capital World Investors
    Large holder · sold 19,842 at $43.65
    866K
    5.6% of stake
  • Nov 12, 2024
    Frank Tobias Baur
    EVP of Operational Excellence · bought 5,310 at $41.42
    220K
    22% of stake
  • Nov 12, 2024
    Thomas S Timko
    EVP, CFO · bought 360 at $40.75
    15K
    0.7% of stake
  • Nov 12, 2024
    Octavio Marquez
    President and CEO · bought 1,690 at avg $40.84
    69K
    1.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DBD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Calculating & Accounting Machines (No Electronic Computers) · Pick stocks to compare with DBD

CompareIntrinsic value
NATLNCR Atleos Corporation
$47.37+1.57%42
VYXNCR Voyix Corp
$9.43+7.16%32
PARPar Technology Corporation
$19.00+4.80%26
PEverpure Inc.
$111.77-5.00%61
FFIVF5 Inc.
$329.72-0.43%88
LOGILogitech International S.A.
$100.12+7.83%90
PBIPitney Bowes Inc.
$16.01+3.22%68
IMMRImmersion Corporation
$7.16+0.85%71

Held by ETFs

DBD is in 82 US ETFs. The largest of them, with DBD's weight in each:

Spot a number that looks wrong? Check it in DBD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DBD

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.